50 Shades of ‘Groundhog Day’

Introduction: The 2017 European Society for Vascular Surgery (ESVS) guidelines on carotid and vertebral artery disease concluded that the evidence did not support a role for carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with asymptomatic carotid stenosis (ACS) in preventi...

Full description

Bibliographic Details
Main Author: A. Ross Naylor
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:EJVES Vascular Forum
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666688X22000430
_version_ 1797990605620510720
author A. Ross Naylor
author_facet A. Ross Naylor
author_sort A. Ross Naylor
collection DOAJ
description Introduction: The 2017 European Society for Vascular Surgery (ESVS) guidelines on carotid and vertebral artery disease concluded that the evidence did not support a role for carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with asymptomatic carotid stenosis (ACS) in preventing cognitive impairment or dementia. What new data have emerged since 2017, and have they influenced the 2023 ESVS guidelines? Report: In a systematic review, 33/35 studies (94%) reported a “significant association” between ACS and cognitive impairment; 20 studies had 1–3 tests with significant cognitive impairment; 10 reported 4–6 tests with cognitive impairment; and three studies reported ≥7 tests with significant cognitive impairment. Baseline data from 1 000 patients with ACS in the second Carotid Revascularisation Endarterectomy versus Stenting Trial (CREST-2) reported that the overall Z score for cognition in patients with ACS was significantly lower than expected, especially for word list recall and word list learning. Another systematic review reported that (in the long term) 69% of patients with ACS undergoing CEA/CAS had no change in cognitive function. However, in another 25%, cognitive scores/domains were mostly unchanged, but 1–2 individual tests were significantly improved. In addition, 1 601 UK and Swedish patients with ACS were randomised in the first Asymptomatic Carotid Surgery Trial (ACST-1) to CEA or best medical therapy (BMT). There was no difference in 10 year rates of dementia (CEA 6.7% vs. 6.6% with BMT) or at 20 years (14.3% [CEA] vs. 15.5% [BMT]), suggesting that CEA did not prevent dementia vs. BMT (hazard ratio 0.98, 95% confidence interval 0.75–1.28; p = .89). Discussion: ACS is associated with significant cognitive impairment, but whether this supports a direct aetiological role, or a marker for something else, remains unknown. There is no evidence that CEA/CAS prevents late dementia. The 2023 ESVS guidelines have not changed its recommendation compared with the 2017 version.
first_indexed 2024-04-11T08:39:15Z
format Article
id doaj.art-d7f13dcc79024e8687d6f9ed9041d8fb
institution Directory Open Access Journal
issn 2666-688X
language English
last_indexed 2024-04-11T08:39:15Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series EJVES Vascular Forum
spelling doaj.art-d7f13dcc79024e8687d6f9ed9041d8fb2022-12-22T04:34:15ZengElsevierEJVES Vascular Forum2666-688X2022-01-0156373950 Shades of ‘Groundhog Day’A. Ross Naylor0Corresponding author. The Leicester Vascular Institute, Glenfield Hospital, Leicester LE3 9QP, UK; The Leicester Vascular Institute, Glenfield Hospital, Leicester, UKIntroduction: The 2017 European Society for Vascular Surgery (ESVS) guidelines on carotid and vertebral artery disease concluded that the evidence did not support a role for carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with asymptomatic carotid stenosis (ACS) in preventing cognitive impairment or dementia. What new data have emerged since 2017, and have they influenced the 2023 ESVS guidelines? Report: In a systematic review, 33/35 studies (94%) reported a “significant association” between ACS and cognitive impairment; 20 studies had 1–3 tests with significant cognitive impairment; 10 reported 4–6 tests with cognitive impairment; and three studies reported ≥7 tests with significant cognitive impairment. Baseline data from 1 000 patients with ACS in the second Carotid Revascularisation Endarterectomy versus Stenting Trial (CREST-2) reported that the overall Z score for cognition in patients with ACS was significantly lower than expected, especially for word list recall and word list learning. Another systematic review reported that (in the long term) 69% of patients with ACS undergoing CEA/CAS had no change in cognitive function. However, in another 25%, cognitive scores/domains were mostly unchanged, but 1–2 individual tests were significantly improved. In addition, 1 601 UK and Swedish patients with ACS were randomised in the first Asymptomatic Carotid Surgery Trial (ACST-1) to CEA or best medical therapy (BMT). There was no difference in 10 year rates of dementia (CEA 6.7% vs. 6.6% with BMT) or at 20 years (14.3% [CEA] vs. 15.5% [BMT]), suggesting that CEA did not prevent dementia vs. BMT (hazard ratio 0.98, 95% confidence interval 0.75–1.28; p = .89). Discussion: ACS is associated with significant cognitive impairment, but whether this supports a direct aetiological role, or a marker for something else, remains unknown. There is no evidence that CEA/CAS prevents late dementia. The 2023 ESVS guidelines have not changed its recommendation compared with the 2017 version.http://www.sciencedirect.com/science/article/pii/S2666688X22000430Asymptomatic carotid diseaseCognitive functionDementia
spellingShingle A. Ross Naylor
50 Shades of ‘Groundhog Day’
EJVES Vascular Forum
Asymptomatic carotid disease
Cognitive function
Dementia
title 50 Shades of ‘Groundhog Day’
title_full 50 Shades of ‘Groundhog Day’
title_fullStr 50 Shades of ‘Groundhog Day’
title_full_unstemmed 50 Shades of ‘Groundhog Day’
title_short 50 Shades of ‘Groundhog Day’
title_sort 50 shades of groundhog day
topic Asymptomatic carotid disease
Cognitive function
Dementia
url http://www.sciencedirect.com/science/article/pii/S2666688X22000430
work_keys_str_mv AT arossnaylor 50shadesofgroundhogday